124 related articles for article (PubMed ID: 35175470)
1. Genetic Markers of Therapeutic Efficacy of Methotrexate in Patients with Psoriasis.
Voron'ko OE; Baskaev KK; Sobolev VV; Denisova EV; Korsunskaya IM
Bull Exp Biol Med; 2022 Feb; 172(4):460-463. PubMed ID: 35175470
[TBL] [Abstract][Full Text] [Related]
2. Genetic Determinants of Methotrexate Toxicity in Tunisian Patients with Rheumatoid Arthritis: A Study of Polymorphisms Involved in the MTX Metabolic Pathway.
Chaabane S; Marzouk S; Akrout R; Ben Hamad M; Achour Y; Rebai A; Keskes L; Fourati H; Bahloul Z; Maalej A
Eur J Drug Metab Pharmacokinet; 2016 Aug; 41(4):385-93. PubMed ID: 26077125
[TBL] [Abstract][Full Text] [Related]
3. Associations between single-nucleotide polymorphisms of RFC-1, GGH, MTHFR , TYMS, and TCII genes and the efficacy and toxicity of methotrexate treatment in patients with rheumatoid arthritis.
Świerkot J; Ślęzak R; Karpiński P; Pawłowska J; Noga L; Szechiński J; Wiland P
Pol Arch Med Wewn; 2015; 125(3):152-61. PubMed ID: 25599563
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms in the thymidylate synthase and methylenetetrahydrofolate reductase genes and sensitivity to the low-dose methotrexate therapy in patients with rheumatoid arthritis.
Kumagai K; Hiyama K; Oyama T; Maeda H; Kohno N
Int J Mol Med; 2003 May; 11(5):593-600. PubMed ID: 12684695
[TBL] [Abstract][Full Text] [Related]
5. Tyms double (2R) and triple repeat (3R) confers risk for human oral squamous cell carcinoma.
Bezerra AM; Sant'Ana TA; Gomes AV; de Lacerda Vidal AK; Muniz MT
Mol Biol Rep; 2014 Dec; 41(12):7737-42. PubMed ID: 25341694
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms of methylenetetrahydrofolate reductase (MTHFR), methionine synthase (MTR), methionine synthase reductase (MTRR), and thymidylate synthase (TYMS) in multiple myeloma risk.
Lima CS; Ortega MM; Ozelo MC; Araujo RC; De Souza CA; Lorand-Metze I; Annichino-Bizzacchi JM; Costa FF
Leuk Res; 2008 Mar; 32(3):401-5. PubMed ID: 17655928
[TBL] [Abstract][Full Text] [Related]
7. Influence of polymorphisms in MTHFR 677 C→T, TYMS 3R→2R and MTR 2756 A→G on NSCLC risk and response to platinum-based chemotherapy in advanced NSCLC.
Cui LH; Yu Z; Zhang TT; Shin MH; Kim HN; Choi JS
Pharmacogenomics; 2011 Jun; 12(6):797-808. PubMed ID: 21605004
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenetic study of methylenetetrahydrofolate reductase and thymidylate synthase in Japanese and assessment of ethnic and gender differences.
Inoue S; Hashiguchi M; Chiyoda T; Sunami Y; Tanaka T; Mochizuki M
Pharmacogenomics; 2007 Jan; 8(1):41-7. PubMed ID: 17187508
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenetic study of 5,10-methylenetetrahydrofolate reductase C677T and thymidylate synthase 3R/2R gene polymorphisms and methotrexate-related toxicity in Chinese Han patients with inflammatory arthritis.
Zeng QY; Wang YK; Xiao ZY; Chen SB
Ann Rheum Dis; 2008 Aug; 67(8):1193-4. PubMed ID: 18621970
[No Abstract] [Full Text] [Related]
10. Methylenetetrahydrofolate reductase and thymidylate synthase genotypes and risk of acute graft-versus-host disease following hematopoietic cell transplantation for chronic myelogenous leukemia.
Robien K; Bigler J; Yasui Y; Potter JD; Martin P; Storb R; Ulrich CM
Biol Blood Marrow Transplant; 2006 Sep; 12(9):973-80. PubMed ID: 16920564
[TBL] [Abstract][Full Text] [Related]
11. Methylenetetrahydrofolate reductase (MTHFR) C677T and thymidylate synthase promoter (TSER) polymorphisms in Indonesian children with and without leukemia.
Giovannetti E; Ugrasena DG; Supriyadi E; Vroling L; Azzarello A; de Lange D; Peters GJ; Veerman AJ; Cloos J
Leuk Res; 2008 Jan; 32(1):19-24. PubMed ID: 17395259
[TBL] [Abstract][Full Text] [Related]
12. Influence of folate pathway polymorphisms on high-dose methotrexate-related toxicity and survival in childhood acute lymphoblastic leukemia.
Erčulj N; Kotnik BF; Debeljak M; Jazbec J; Dolžan V
Leuk Lymphoma; 2012 Jun; 53(6):1096-104. PubMed ID: 22074251
[TBL] [Abstract][Full Text] [Related]
13. The influence of methylenetetrahydrofolate reductase and thymidylate synthetase gene polymorphisms on lung adenocarcinoma occurrence.
Cavic M; Krivokuca A; Spasic J; Brotto K; Malisic E; Radosavljevic D; Radulovic S; Jankovic R
J BUON; 2014; 19(4):1024-8. PubMed ID: 25536611
[TBL] [Abstract][Full Text] [Related]
14. Interactions of 5'-UTR thymidylate synthase polymorphism with 677C → T methylene tetrahydrofolate reductase and 66A → G methyltetrahydrofolate homocysteine methyl-transferase reductase polymorphisms determine susceptibility to coronary artery disease.
Vijaya Lakshmi SV; Naushad SM; Rupasree Y; Seshagiri Rao D; Kutala VK
J Atheroscler Thromb; 2011; 18(1):56-64. PubMed ID: 20962453
[TBL] [Abstract][Full Text] [Related]
15.
Sundbaum JK; Baecklund E; Eriksson N; Hallberg P; Kohnke H; Wadelius M
Pharmacogenomics; 2020 Apr; 21(5):337-346. PubMed ID: 32024416
[No Abstract] [Full Text] [Related]
16. Association study of the common polymorphisms in the folate-methionine pathway with retinoblastoma.
Soleimani E; Saliminejad K; Akbari MT; Kamali K; Ahani A
Ophthalmic Genet; 2016 Dec; 37(4):384-387. PubMed ID: 26914443
[TBL] [Abstract][Full Text] [Related]
17. Association of hyperhomocysteinemia with genetic variants in key enzymes of homocysteine metabolism and methotrexate toxicity in rheumatoid arthritis patients.
Chaabane S; Messedi M; Akrout R; Ben Hamad M; Turki M; Marzouk S; Keskes L; Bahloul Z; Rebai A; Ayedi F; Maalej A
Inflamm Res; 2018 Aug; 67(8):703-710. PubMed ID: 29796841
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms of MTHFR and TYMS predict capecitabine-induced hand-foot syndrome in patients with metastatic breast cancer.
Lin S; Yue J; Guan X; Yuan P; Wang J; Luo Y; Fan Y; Cai R; Li Q; Chen S; Zhang P; Li Q; Ma F; Xu B
Cancer Commun (Lond); 2019 Oct; 39(1):57. PubMed ID: 31601265
[TBL] [Abstract][Full Text] [Related]
19. Influence of thymidylate synthase and methylenetetrahydrofolate reductase gene polymorphisms on the disease-free survival of breast cancer patients receiving adjuvant 5-fluorouracil/methotrexate-based therapy.
Paré L; Altés A; Ramón y Cajal T; Del Rio E; Alonso C; Sedano L; Barnadas A; Baiget M
Anticancer Drugs; 2007 Aug; 18(7):821-5. PubMed ID: 17581305
[TBL] [Abstract][Full Text] [Related]
20. Are Thymidylate synthase and Methylene tetrahydrofolate reductase genes linked with methotrexate response (efficacy, toxicity) in Indian (Asian) rheumatoid arthritis patients?
Ghodke Y; Chopra A; Joshi K; Patwardhan B
Clin Rheumatol; 2008 Jun; 27(6):787-9. PubMed ID: 18274813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
